Mirae Asset Global Investments Co., Ltd. Adma Biologics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,877 shares of ADMA stock, worth $164,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,877
Previous 8,430
6.56%
Holding current value
$164,708
Previous $168,000
19.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
343Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$390 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$381 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$311 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$236 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$116 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...